2025-12-30 - Analysis Report
Okay, here's a breakdown of the Linde PLC (LIN) analysis based on the provided data:

**1) Return Comparison:**

*   **LIN Company Overview:** Linde PLC is a global industrial gases and engineering company.
*   **LIN Cumulative Return:** 61.65%
*   **S&P 500 (VOO) Cumulative Return:** 103.21%
*   **Divergence:** -40.56% (current), Relative Divergence: 11.5

    *   **Analysis:** Linde has significantly underperformed the S&P 500 over the analyzed period. The divergence is currently -40.56%, indicating that LIN's cumulative return is 40.56 percentage points lower than the S&P 500. The relative divergence of 11.5 suggests that the current divergence is near the lower end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B)  |
| :---------- | :----- | :----- | :----- | :----- | :------ |
| 2015-2017  | 36.0%  | 9.2%   | 8.0%   | 0.0    | 72.8    |
| 2016-2018  | 27.0%  | 69.9%  | 12.0%  | 0.2    | 73.5    |
| 2017-2019  | 41.0%  | 69.9%  | 19.0%  | 0.4    | 100.2   |
| 2018-2020  | 14.0%  | 78.6%  | -10.0% | 0.4    | 124.1   |
| 2019-2021  | 63.0%  | 78.6%  | 16.0%  | 0.9    | 163.1   |
| 2020-2022  | 37.0%  | 78.6%  | 38.0%  | 0.8    | 153.6   |
| 2021-2023  | 43.0%  | 76.7%  | 41.0%  | 0.5    | 193.4   |
| 2022-2024  | 6.0%   | 76.7%  | -14.0% | 0.5    | 197.1   |
| 2023-2025  | -12.0% | 79.5%  | -80.0% | 0.5    | 200.0   |

*   **CAGR:** Fluctuates significantly over the periods, ranging from -12% to 63%.  Recent periods show lower or negative growth.
*   **MDD (Maximum Drawdown):** High MDD values across the board suggest significant potential for price declines.
*   **Alpha:**  Represents excess return compared to the benchmark. Recent periods show strongly negative Alpha, especially in 2023-2025.
*   **Beta:** Relatively low, indicating LIN is less volatile than the overall market.
*   **Capitalization:** The company has grown its capitalization significantly over the years.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 424.77
*   **Last Market:** Price 426.54, Previous Close 424.83, Change 0.4%
*   **5-day SMA:** 423.94
*   **20-day SMA:** 411.44
*   **60-day SMA:** 427.56

    *   **Analysis:** The stock is currently trading above both its 5-day and 20-day Simple Moving Averages (SMAs), but below its 60-day SMA. The price increase in the last market session indicates short-term positive momentum. The 20-day SMA is well below the current price, suggesting that the price is trending up from its recent average.

**3) Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 72.79 (Approaching overbought)
*   **PPO:** 0.74
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (2 shares - Safe (OverSold Boost) - MRI:0.80) Dividend_1.50" (Suggests a buy signal based on the MRI, potential oversold conditions, and a dividend.)
*   **Recent (20 days) relative divergence change:** 1.7 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** 233.6% (Long-term)

    *   **Analysis:** The MRI suggests a generally favorable investment climate. However, the RSI is approaching overbought territory, which could signal a potential pullback. The Hybrid Signal is strongly bullish. The expected return is very high, suggesting that the model anticipates significant outperformance over the long term, given the current valuation.

**4) Recent News & Significant Events:**

*   **Cwm LLC Purchased Shares:** Indicates institutional investor interest.
*   **Cramer's Critique and New Credit Facility:** Suggests possible controversy or uncertainty balanced by positive financial developments.
*   **Linde Stock Edging Higher (Tech Retreat Context):** Shows resilience despite broader market weakness.
*   **Linde's 5-Year Returns:** Highlights strong historical performance.
*   **Xiaomi Share Sale (Unrelated):** Seemingly unrelated, check relevance.
*   **Linde Stock Price Prediction (TIKR):** Provides an external analyst view.

    *   **Analysis:** The news is a mixed bag. Institutional buying and resilience in a down market are positive. Cramer's critique and a new credit facility need further investigation.

**4-2) Analyst Opinions:**

*   **Consensus:** Strong Buy (Mean: 1.5)
*   **Opinions:** 24
*   **Target Price:** Avg: 502.71, High: 565.00, Low: 381.00

    *   **Analysis:** Analysts are overwhelmingly positive on Linde, with a strong buy consensus. The average target price suggests potential upside.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
| :---------- | :---- | :--------- |
| 2025-10-31 | 4.11 | 8.62 B$   |
| 2025-08-01 | 3.75 | 8.49 B$   |
| 2025-05-01 | 3.53 | 8.11 B$   |
| 2024-10-31 | 3.24 | 8.36 B$   |
| 2025-10-31 | 3.24 | 8.36 B$   |

* **Analysis:** The table shows increasing EPS and revenue over the last quarters, indicating healthy growth. However, there's a duplicate entry for 2025-10-31 with the same EPS and revenue as 2024-10-31, which should be verified.
* The trend of EPS and revenue shows growth.

**6) Financial Information: Revenue and Profitability**

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :-------------- |
| 2025-09-30 | $8.62B     | 49.17%          |
| 2025-06-30 | $8.49B     | 49.31%          |
| 2025-03-31 | $8.11B     | 48.75%          |
| 2024-12-31 | $8.28B     | 47.84%          |
| 2024-09-30 | $8.36B     | 47.87%          |

*   **Analysis:** Revenue has generally been increasing over the last several quarters. Profit margins are consistently high and also improving, indicating strong operational efficiency.

**Financial Information: Capital and Profitability**

| Quarter    | Equity     | ROE   |
| :--------- | :--------- | :---- |
| 2025-09-30 | $38.62B    | 5.00% |
| 2025-06-30 | $38.52B    | 4.59% |
| 2025-03-31 | $38.03B    | 4.40% |
| 2024-12-31 | $38.09B    | 4.53% |
| 2024-09-30 | $39.17B    | 3.96% |

*   **Analysis:** Equity is relatively stable. ROE (Return on Equity) has been increasing, which is a positive sign of improved profitability relative to shareholders' equity.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** Linde has underperformed the S&P 500 significantly over the analyzed period.
*   **Recent Momentum:** Short-term price momentum is positive.
*   **Mixed Signals:** The MRI is bullish, but the RSI is approaching overbought.
*   **Analyst Sentiment:** Analysts are strongly bullish.
*   **Strong Fundamentals:** Recent earnings, revenue growth, and high/improving profit margins and ROE suggest good financial health.
*   **Potential Risk:** High MDD values indicate a potential for large price declines, as seen from the table on Alpha, Beta analysis.
*   **Buy Signal:** Given a lot of bullish indicators, this should be a good buy.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.